Northern Trust
SNOA icon

Northern Trust’s Sonoma Pharmaceuticals SNOA Stock Holding History

Northern Trust’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-22
Closed -$19K – 4268
2016
Q1 		$19K Buy
22
+1
+5% +$929 ﹤0.01% 4139
2015
Q4 		$22K Sell
21
-1
-5% -$1.07K ﹤0.01% 4161
2015
Q3 		$26K Buy
+22
New +$26.1K ﹤0.01% 4160

Other funds holding SNOA

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Northern Trust's SNOA Position: Q2 2016 in Review

Northern Trust sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2016, closing a stake of 22 shares — an estimated $19K sold.

Northern Trust first reported a position in SNOA in Q3 2015 and held it in 3 quarters. The position peaked at $26K in Q3 2015. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2016.

  • Northern Trust reported no remaining Sonoma Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Northern Trust sold 22 Sonoma Pharmaceuticals shares in Q2 2016, an estimated $19K.
  • Northern Trust first reported a position in Sonoma Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Northern Trust's Sonoma Pharmaceuticals position peaked at $26K in Q3 2015.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2016.

Based on Northern Trust's 13F filing for Q2 2016, filed 12 Aug 2016.